MedIntelliBase® NewsTips     May/June 2007
Your monthly newsletter from the
"better way to access market intelligence" people at

MedIntelliBase®NewsTips...A Better stay up-to-date

Table of Contents
1) Science, Innovation, Synergy - SIS 2007 Conference in Seattle
  • SIS 2007 - A Course in Cardiac, Vascular, and Neurovascular Therapeutics & Emerging Technology Symposium
2) "SONOMA" study now joins "CABERNET"
  • SONOMA - NexStent Carotid Stent System and FilterWire EZ Embolic Protection System
3) MedIntelliBase SMArt Stats
  • MIB SMArt Stats - Customized procedure data based on CPT and ICD-9 code maps
4) Link of the Month
5) Fun Fact of the Month
6) A Better Access Market Intelligence
7) SidePinch® Clamps (SPCs)
  • SidePinch Clamps - Simple, innovative, incredibly useful - in demand by doctors, nurses, and techs needing easy fluid flow control
8) More Information Available at
Return to Top

1) Science, Innovation, Synergy - SIS 2007 Conference in Seattle
A Course in Cardiac, Vascular, and Neurovascular Therapeutics & Emerging Technology Symposium

Look for several special MIB NewsTips issues over the next few weeks describing the upcoming SIS 2007 conference, August 1-4. This combined comprehensive course and emerging technology symposium is directed by opinion leaders in vascular medicine and is intended for those medical professionals and industry experts with a clinical or technical interest in interventional medicine.

SIS 2007
Visit the SIS conference site for more information by clicking the SIS 2007 logo. We hope to see you in Seattle at SIS 2007!

Return to Top

2) "SONOMA" now joins "CABERNET"

Boston Scientific Corporation has announced the "Post-Market Approval Study of the NextStent Carotid Stent System and the FilterWire EZ Embolic Protection System." This "SONOMA" Post-Market Approval study, a multi-center, U.S. surveillance registry, enrolled the first of 1,650 patients on May 31, 2007. One hundred sites are planned with scheduled closure of the registry in September 2009. The study will confirm the safety of the NexStent Carotid Stent System and FilterWire EZ Embolic Protection System used in daily clinical practice for the approved indications.

To review a detailed overview of the study as depicted below in a SMArt Trial Summary at, go to "SONOMA" study.

SONOMA study

Subbarao Myla, M.D., Medical Director of Cardiovascular Research and Vascular Intervention, Hoag Heart and Vascular Institute, Hoag Memorial Hospital Presbyterian Newport Beach, CA, the principal investigator for SONOMA, enrolled the first patient. In the BSCI press release issued June 1, Dr. Myla was quoted as saying "We are hopeful that the unique design and other features of the NexStent Carotid Stent and FilterWire EZ Embolic Protection System will facilitate a high procedure success rate and relatively low risk of major disabling stroke or death in a cohort of patients with symptomatic and asymptomatic carotid artery stenosis that are at high risk for surgery." A 500-patient cohort will be included to allow an independent core lab to review analyze patient success based on routine duplex ultrasound evaluations.

The "CABERNET" Multi-center Trial ["Carotid Artery Revascularization Using the Boston Scientific EPI FilterWiRe EX and the Endotex NExStenT"] results supported the FDA’s October 27, 2006 PMA approval of both devices. Published September 23, 2005, the CABERNET trail was designed for 600 patients and concluded with 454 patients enrolled, with 438 showing a stroke rate of 1.3 percent, and a combined stroke, death, and MI rate of 3.9 percent. To review the final trial results in a SMArt Trial Summary at, go to "CABERNET".

These SMArt Trial summaries and over 800 others are available to subscribers to MedIntelliBase MarketTracks databases. Contact us to access specific and/or customized clinical trial and registry summaries of interest to you.

Interested in keeping up to date on this issue? Is there another area of interest where you need current, timely clinical research or technology development information? Click here to learn more about our MIB Alerts - A Better stay up to date.

Return to Top

3) MedIntelliBase SMArt Stats - Custom U.S. Healthcare Procedure Data

Announcing a new service! The Next Phase Publishing is pleased and excited to announce its newest offering, MIB SMArt Stats. MIB SMArt Stats offer users customized U.S. procedure data based on the American Medical Association's Current Procedural Technology (CPT) and International Classification of Diseases (ICD-9) coding systems.

Utilizing data sets available from U.S. governmental sources including the Centers for Medicare & Medicaid Services (CMS) and the Agency for Healthcare Research and Quality (AHRQ), procedure volumes and associated charge data are now easy and quick for you to access. For any and all CPT codes that you need by year, MIB SMArt Stats reports can take you to the state and municipal area levels of granularity. Up to 20 additional, directly associated data fields are available providing details on carriers and physicians for each procedure.

Until now, the process has been complex. If you venture into this alone it can consume hundreds of hours of your team's valuable time and innumerable resources to generate accurate and usable data tables and reports. MIB SMArt Stats changes all of this and provides all data for you, quickly, easily, and accurately. If you have any questions about MIB SMArt Stats or would like further information about our customized service, go to MIB SMArt Stats Info Request form or contact us directly.

Is there another area of interest where you need current, timely clinical research or technology development information? Click here to learn more about our MIB Alerts - A Better stay up to date.

Return to Top

4) Link of the Month
  • Calcium & Vitamin D may not reduce risk of heart disease or stroke - A study recently published in Circulation, the journal of the American Heart Association, suggests that over seven years of use calcium and vitamin D supplements do not affect the risk of heart disease or stroke in generally healthy postmenopausal women. []
Return to Top

5) Fun Fact of the Month
  • Is a good "belly laugh" good for your heart?- Dr. Michael Miller of the University of Maryland School of Medicine in Baltimore and colleagues have demonstrated for the first time that laughter is linked to healthy function of blood vessels. Laughter appears to cause the tissue that forms the inner lining of blood vessels, the endothelium, to dilate or expand in order to increase blood flow. []
Return to Top

6) MedIntelliBase Custom Email Alerts now give you A Better Way

Coming in July - MedIntelliBase Custom Email Alerts with newly updated capabilities including Full-Featured Search. Search any or all of these databases customized to your area of interest:
  • Abstracts Library
  • Alerts Library
  • Full Text Article Library
  • MarketTracks...detailed SMArt Summaries™ on breaking clinical trials & registries, and emerging technologies.
MIB Alerts
Click the image above to view sample MIB Custom Email Alert formats - a "FullView" Alert, or one of the "QuickView" formats --> Lean Alert or UltraLean Alert.

A Better Way
Does this "quest for Market Intelligence" sound familiar?
  1. Search for market, clinical, or technology "intelligence"
  2. Agonize over the high prices
  3. "Bite the bullet" and purchase an email alert service
  4. Sort through reams of semi-useful results with every alert
  5. Marvel at the lack of precise targeting and time you spend using your human intelligence to screen-out bad results
  6. Give up and spend hours trying to find the latest developments on Medline or Google
  7. Search for hours to find that one abstract or press release from 3 or 4 months ago that supports your point
  8. Get frustrated at the inability to find what you need
  9. Write your report or your business plan that you know should be better, more in depth and more precise...if only you had better information
  10. Vow that next time, you’ll find a better way
MedIntelliBase Alerts now powered by
  • WebGUI search capabilities
  • MarketTracks databases
give you just that...A Better Way to stay updated on the industry developments important to you.

     MIB Alerts
MedIntelliBase Custom Email Alerts are highly flexible, customized intelligent search filters powered by "Human Intelligence™" that give you convenient, timely, and tightly focused updates on new developments in your industry segment. MIB Alerts are especially suitable for busy Marketing, Business Development, and General Management executives in medical device and biotechnology companies.

Convenient and Timely
    • Respond to new developments in real time, not weeks or months later
    • Keep you up-to-date on relevant industry events and announcements as they occur
    • Pushed to you via email, no need to login for news
Easy to use
    • MIB Alerts do the work for you. You become the "industry expert" in your organization
    • Easy-to-read and navigate Alerts and archives
    • Fully-searchable online libraries of abstracts, articles, Alerts, clinical trial and technology summaries - you choose and customize to your exact requirements
    • Easy-to-search libraries of abstracts, Alerts or articles that return  documents quickly, within your first query
    • Accessible from anywhere, from Outlook or any web browser
Customized and Tightly Focused
    • Save you time and make you more effective
    • You receive only those specific developments that matter to you
    • You don't receive useless filler and irrelevant search hits - MIB's "Human Intelligence" removes the fluff
A few examples of thousands of possibilities for Alert topics:

Cardiac, Cardiovascular and Vascular
  • Peripheral Arterial Occlusion (PAO)- Thrombolysis
  • Cardiac Structural Defects
  • Lower Limb PAD & Atherectomy
  • PV Angiography - Infusion Catheters
  • CV/PV Angiography - Power Injectors
  • Deep Vein Thrombosis (DVT) - Thrombolysis
  • Neurostimulation - Hearing Loss
  • Neurostimulation - Alzheimer's disease
  • Neurostimulation - Parkinson's disease
  • Drugs and Advanced Therapies - Parkinson's disease & Essential Tremor
  • Neurostimulation - Epilepsy
  • Neurostimulation - Pain Management
  • Spinal Motion Preservation
  • Hip Resurfacing
  • Knee Resurfacing
Emergency Medicine
  • Resuscitation
View a sampling of Custom Email Alerts
Customize your Alerts with the type of information you specify:
  • Clinical article abstracts
  • Trials and registries results
  • Preclinical article abstracts
  • Industry announcements
  • Press releases
  • Conference notices & proceedings
  • Technology developments
  • Patents issued & challenged
  • Lawsuits & other legal issues
  • FDA & voluntary product recalls
  • And more
Other custom consulting options:
  • Tracking of established and emerging technologies, landmark and breaking trials and competing companies
  • Strategic analysis and recommendations
  • Market potential assessments
You get much greater value from customizable MIB Alerts than from standard market reports and search engines. You choose the exact depth and breadth of intelligence required, realizing the greatest value for your market intelligence money.

Interested? Want to know more? Want a trial?

Contact us for:
  • More information
  • Real-Time MedIntelliBase Custom Email Alerts  Tour
Return to Top

7) SidePinch Clamps

SidePinch Clamps (SPCs) are in demand for easy "on-off" use...
  • One hand operation - place, lock, unlock
  • Easy on, easy off
  • No need to break any connection
  • Available in a variety of colors and sizes
  • Custom configurations available
SPCs are designed for on-demand fluid flow control in a variety of clinical, medical, emergency and laboratory settings.

Doctors, nurses, lab technicians and other medical practitioners require smarter closing, clamping and contamination-prevention devices which are easy-to-use and a great value...SidePinch Clamps meet their needs.

Find out how by visiting

Return to Top

8) More Information Available at

You can find more in-depth information about MedIntelliBase Custom Email Alerts - visit the website at or request more information on the site.

MedIntelliBase MarketTracks and Alerts will help you find the critical intelligence you need to make informed product development and business investment decisions.

Contact MedIntelliBase directly...

Return to Top

  1. MedIntelliBase NewsTips is free and you are welcome to continue receiving it as long as you wish. If at any time you wish to cancel just click the Safe Unsubscribe link below.
  2. We will not share your name and e-mail address with anyone.
  3. Feel free to share or reproduce the information in this MedIntelliBase NewsTips e-newsletter (in whole or part) as long as proper mention and copyright notice is given to MedIntelliBase and The Next Phase Publishing**.
  4. If you are not the original recipient of this newsletter and would like to receive future issues, just click the Forward link below or drop us a line.

Editor: Vicky Hunsicker Sanko
The Next Phase Publishing**

Market Research Analyst: Jordan Zornes
The Next Phase Publishing**
Phone - 425/894-4147
Toll Free - 800/390-2756
Fax - 866/381-6119

** A division of Next Phase® Consultancy, Inc.

© The Next Phase® Consultancy, Inc. 2007. All rights reserved.

Return to Top